A Phase II Trial of Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Carboplatin; Topotecan
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 26 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jul 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 09 Nov 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.